Edition:
United States

Chemed Corp (CHE.N)

CHE.N on New York Stock Exchange

231.61USD
17 Nov 2017
Change (% chg)

$-1.46 (-0.63%)
Prev Close
$233.07
Open
$231.72
Day's High
$233.93
Day's Low
$231.29
Volume
39,219
Avg. Vol
30,764
52-wk High
$235.72
52-wk Low
$145.09

Chart for

About

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians,... (more)

Overall

Beta: 1.14
Market Cap(Mil.): $3,697.89
Shares Outstanding(Mil.): 15.97
Dividend: 0.28
Yield (%): 0.48

Financials

  Industry Sector
P/E (TTM): -- 30.21 15.79
EPS (TTM): -- -- --
ROI: -- 7.97 12.01
ROE: -- 11.82 15.91

BRIEF-Chemed reaches final agreement to end civil litigation & false claims act brought by U.S. DOJ in May 2013​

* Chemed - Reached final agreement to end civil litigation and false claims act brought by U.S. Department of Justice in May 2013​

Oct 31 2017

Chemed to pay $75 million over false claims lawsuit: Justice Dept

WASHINGTON Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

Oct 30 2017

Chemed to pay $75 mln over false claims lawsuit -Justice Dept

WASHINGTON, Oct 30 Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

Oct 30 2017

BRIEF-Chemed reports Q3 earnings per share $2.13

* Sees FY 2017 adjusted earnings per share $8.35 to $8.40 excluding items

Oct 26 2017

BRIEF-Chemed Corp increases quarterly dividend 7.7 pct

* Says declared quarterly cash dividend of 28-cents per share Source text for Eikon: Further company coverage:

Aug 04 2017

BRIEF-Chemed Corp qtrly ‍adjusted diluted eps $2.15​

* Chemed Corp qtrly ‍net patient revenue of $285 million, an increase of 2.1%​

Jul 25 2017

Earnings vs. Estimates